Latest Lead News

Celsius Resources has postponed the final Feasibility Study for its Maalinao-Caigutan-Biyog Copper-Gold Project to January 2026, while engaging a top financial advisory firm to secure project financing amid strong international interest.

Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.

ActivEX Limited has completed a $100,000 share placement with Business Victor Investments Limited, aiming to accelerate its exploration activities and strengthen working capital.

Australian Ethical Investment Ltd has released its 2026 reporting calendar, outlining important dates for financial disclosures, dividends, and corporate governance events.

The FDA’s recent ruling classifying traditionally prepared kava beverages as food under U.S. law clears a major regulatory hurdle for The Calmer Co, accelerating its growth on Amazon and strengthening its U.S. expansion strategy.

Electro Optic Systems (EOS) has landed a US$22 million deal to supply Remote Weapon Systems for a major U.S. Army combat vehicle, marking a significant milestone in its U.S. market expansion. This contract boosts EOS’s contract backlog to over A$400 million, setting the stage for robust revenue growth in the coming years.

InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.

Perseus Mining has expanded and refinanced its corporate debt facility to US$400 million, significantly enhancing its liquidity position to over US$1.2 billion. This move positions the gold miner strongly for future growth and shareholder returns.

The Supreme Court of New South Wales has approved Southern Cross Media's acquisition of Seven West Media, setting the stage for a significant media industry consolidation early next year.

Wingara AG Limited has arranged a $250,000 unsecured loan facility from NAOS Asset Management entities, featuring a convertible note option that could reshape its capital structure.

American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.